Safety and efficacy of single agent rovalpituzumab tesirine in small cell lung cancer (SCLC)
1 Mga view
• 07/14/23
0
0
I-embed
administrator
Mga subscriber
Press brief by Charles Rudin, MD, PhD of the Memorial Sloan Kettering Cancer Center, New York, NY, at the 2016 Annual Meeting of the American Society of Clinical Oncology (ASCO), held in Chicago, IL.
Magpakita ng higit pa
Mga Komento sa Facebook
SORT BY-
Mga Nangungunang Komento
-
Pinakabagong komento